SHE:001367 Revenue

Zhejiang Haisen Pharmaceutical had revenue of 107.19M CNY in the quarter ending March 31, 2026, a decrease of -9.53%. This brings the company's revenue in the last twelve months to 520.97M, up 9.87% year-over-year. In the year 2025, Zhejiang Haisen Pharmaceutical had annual revenue of 532.26M with 12.88% growth.

Revenue (ttm)

520.97M

Revenue Growth

+9.87%

P/S Ratio

6.84

Revenue / Employee

738.97K

Employees

705

Market Cap

3.56B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	532.26M	60.75M	12.88%
Dec 31, 2024	471.51M	74.06M	18.63%
Dec 31, 2023	397.45M	-25.32M	-5.99%
Jan 1, 2023	422.78M	33.79M	8.69%
Dec 31, 2021	388.98M	104.18M	36.58%
Dec 31, 2020	Pro	Pro	Pro
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Guangdong Jiaying Pharmaceutical	410.00M
Shandong Keyuan Pharmaceutical	448.33M
Shanghai Shenqi Pharmaceutical Investment Management	1.95B
Zhejiang Zhenyuan Share	2.67B
Hangzhou Minsheng Healthcare	827.65M
Hubei Guangji Pharmaceutical	638.58M
Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd	211.75M
Zhejiang Int'l Group	33.84B

Revenue Rankings